分子诊断与人工智能在慢性微生物疾病中的整合
本文综述慢性微生物疾病(常由生物膜驱动)的诊断与预后工具。文章指出PCR、杂交、下一代测序和CRISPR检测可实现快速、无创、高灵敏的病原体及耐药标志物检测,基因组学、蛋白质组学、代谢组学等组学技术提供疾病通路见解,人工智能(AI)与大数据的整合增强复杂分子数据解读,支持模式识别、风险预测和个体化治疗决策。
要点
- 分子诊断技术可实现快速、无创、高灵敏的病原体与耐药标志物检测
- 组学技术为慢性微生物疾病的个性化治疗策略提供更深层见解
- AI与大数据分析增强复杂分子数据解读,支持风险预测和个体化治疗决策
核心结论
- 分子诊断与AI驱动的精准医学有望通过早期检测、个体化治疗和更好的疾病管理改善慢性微生物疾病患者结局。
研究设计与样本
- 本文为综述,总结当前及新兴的慢性微生物疾病诊断与预后工具及技术。
主要发现
- PCR、杂交、下一代测序和CRISPR检测可实现快速、无创、高灵敏的病原体与耐药标志物检测。
- 基因组学、蛋白质组学、代谢组学等组学技术提供对疾病通路的更深层见解,有助于个性化治疗策略。
- AI与大数据分析整合增强复杂分子数据集解读,支持模式识别、风险预测和定制治疗决策。
临床怎么用
- 可将分子诊断技术用于慢性微生物疾病的早期精准检测与预后评估。
- 可结合组学技术与AI分析复杂分子数据,辅助个体化治疗决策与疾病管理。
局限性
- 原文未报告具体研究数据、样本量或统计学指标,相关结论基于综述性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic microbial diseases, often driven by biofilm formation, pose a persistent global health burden due to their complex diagnosis, resistance mechanisms, and prolonged disease courses. Conventional diagnostic methods are time-consuming and often insufficient for early, precise detection and prognosis. Recent advances in molecular diagnostics, including PCR, hybridization, next-generation sequencing, and CRISPR-based assays, have enabled rapid, non-invasive, and highly sensitive detection of pathogens and resistance markers. Complementary "omics" technologies, like genomics, proteomics, and metabolomics, provide deeper insights into disease pathways, aiding in personalized treatment strategies. Furthermore, the integration of artificial intelligence (AI) and big data analytics enhances the interpretation of complex molecular datasets, enabling pattern recognition, risk prediction, and tailored therapeutic decisions. This manuscript reviews current tools and emerging technologies for the diagnosis and prognosis of chronic microbial diseases, highlighting the transformative potential of AI-driven precision medicine to improve patient outcomes through early detection, individualized treatment, and better disease management.
引用
- Dutta B, Ray RR. Integrating molecular diagnostics and artificial intelligence in chronic microbial disease. Clin Chim Acta. 2025. PMID: 41456738. doi:10.1016/j.cca.2025.120803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。